Skip to main content
Biotage logo

Biotage — Investor Relations & Filings

Ticker · BIOT ISIN · SE0000454746 LEI · 529900SR87NBUKX74L58 ST Manufacturing
Open in API
Filings indexed 524 across all filing types
Latest filing 2019-01-31 Share Issue/Capital Cha…
Country SE Sweden
Listing ST BIOT

About Biotage

https://www.biotage.com/

Biotage is a global life science company specializing in separation and purification technologies. It provides systems, consumables, and intelligent workflow solutions for customers in drug discovery and development, analytical testing, and diagnostics. The company's portfolio supports a wide range of applications, including medicinal chemistry, peptide synthesis, biomolecule purification (proteins, DNA, oligonucleotides), and automated sample preparation. Key technologies are applied in flash chromatography and analytical testing for clinical, forensic, and environmental samples. Biotage focuses on streamlining laboratory processes to advance scientific research and human health.

Recent filings

Filing Released Lang Actions
Biotage AB – changes in number of shares and votes
Share Issue/Capital Change Classification · 99% confidence The document is a press release from Biotage AB dated January 31, 2019, titled 'Biotage AB – changes in number of shares and votes'. It explicitly states that 487,337 new shares were issued in connection with an acquisition, detailing the change in the total number of outstanding shares from 64,714,447 to 65,201,784. This content directly relates to a change in the company's capital structure via share issuance. This aligns perfectly with the definition for 'Share Issue/Capital Change' (Code: SHA). It is not a general regulatory filing (RNS) because it fits a specific category, nor is it an announcement of a report (RPA).
2019-01-31 English
Biotage AB – förändring i antal aktier och röster
Declaration of Voting Results & Voting Rights Announcements Classification · 99% confidence The document is a press release from Biotage AB dated January 31, 2019, titled 'Biotage AB – förändring i antal aktier och röster' (Biotage AB – change in number of shares and votes). The text explicitly states that 487,337 new shares were issued in January 2019 as part of an acquisition, leading to a new total share count of 65,201,784. This directly concerns a change in the company's capital structure due to new share issuance. This aligns perfectly with the definition for 'Share Issue/Capital Change' (Code: SHA). The document is short and is an announcement of a specific corporate action, not a general regulatory filing (RNS) or a report announcement (RPA).
2019-01-31 Swedish
Biotage genomför förvärv av PhyNexus, Inc. och beslutar om nyemission som en del av förvärvet
M&A Activity Classification · 95% confidence The document is a press release dated January 15, 2019, announcing that Biotage AB has completed the acquisition of PhyNexus, Inc. Crucially, it states that the Board of Directors decided on a new share issue (nyemission) of 487,337 shares as part of the consideration for the acquisition. This action directly relates to changes in the company's capital structure and fundraising/financing activities associated with a corporate transaction (M&A). While it involves M&A (TAR), the primary focus and immediate action announced is the issuance of new shares to fund the deal. This fits best under 'Capital/Financing Update' (CAP) as it details the specific capital change (new share issue) resulting from the transaction, rather than just the M&A proposal itself. It is not a full 10-K, IR, or ER, and it is a specific corporate action announcement, making CAP the most precise fit over the general TAR or RNS.
2019-01-15 Swedish
Biotage completes the acquisition of PhyNexus, Inc. and resolves on a share issue as part of the acquisition
Share Issue/Capital Change Classification · 95% confidence The document is a press release dated January 15, 2019, announcing the completion of an acquisition (PhyNexus, Inc.) and a related resolution by the Board of Directors to issue new shares as part of the consideration. The key actions described are the completion of an M&A transaction and a subsequent share issue/capital structure change. Since the document details the financing activity (share issue) related to the acquisition, it strongly aligns with the 'Capital/Financing Update' (CAP) category. While it mentions an acquisition (TAR), the primary focus and resolution detailed is the issuance of shares to fund it, making CAP a more precise fit than TAR, which usually covers the proposal or agreement itself. It is not a formal regulatory filing like a 10-K or IR, nor is it a simple announcement of a report (RPA/RNS).
2019-01-15 English
Valberedningens förslag till styrelseledamot i Biotage AB
Board/Management Information Classification · 99% confidence The document is a press release dated January 2, 2019, from Biotage AB concerning the Nomination Committee's proposal for a board member ahead of the 2019 Annual General Meeting (Årsstämman). Specifically, it proposes the current CEO, Torben Jørgensen, be elected as a board member. This announcement concerns the composition of the board of directors and management structure leading up to a shareholder meeting. This aligns best with the 'Board/Management Information' category (MANG), as it details a proposed change/addition to the board structure. While it mentions the AGM, the core content is the management/board proposal, not the meeting materials (AGM-R) or voting results (DVA).
2019-01-02 Swedish
The Board of Biotage AB initiates recruitment of a new CEO
Board/Management Information Classification · 99% confidence The document is a press release from Biotage AB dated January 2, 2019. The core subject is the announcement that the Board of Directors has initiated the recruitment process for a new CEO, and the current CEO's future role on the Board. This directly concerns changes in senior management personnel. Based on the definitions, this aligns perfectly with the 'Board/Management Information' category.
2019-01-02 English

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.